Children with non-central nervous system tumors treated with platinum-based chemotherapy are at risk for hearing loss and cognitive impairments

• Váldodahkkit: Allison J. L'Hotta (Dahkki), Anne Spence (Dahkki), Taniya E. Varughese (Dahkki), Kara Felts (Dahkki), Susan S. Hayashi (Dahkki), Megan Jones-White (Dahkki), Emily LaFentres (Dahkki), Judith E. C. Lieu (Dahkki), Robert J. Hayashi (Dahkki), Allison A. King (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2024-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

BackgroundChildhood cancer survivors (CCS) with chemotherapy induced sensorineural hearing loss (SNHL) are at risk for neurocognitive impairments. The purpose of this study was to determine the relationship between SNHL and cognitive function among CCS.ProcedureInclusion: non-CNS solid tumor diagnos...